going strong., page-28

I'm not buying more at these prices, not without new information. And I can't see why anyone would, really. I suspect that most of the acquisition is being done by the same larger buyer that has pushed the price up so sharply in the last four weeks. They either know something we don't or are prepared to pay for a significant stake.

But I'm not tempted to sell at these prices, either. A good deal for Testosterone MD-Lotion, following Phase III success, could involve an up-front payment and milestones totalling more than Acrux's current market cap, plus a royalty. And the sheer number of products in the pipeline (or already being marketed) should bring a steady stream of news. I might unload part of my holding if we see $2 without any announcements, if only to rebalance.